The use of neoadjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatic resection was found to be associated with lower postoperative hospital readmission.

Read more: https://www.docwirenews.com/docwire-pick/neoadjuvant-therapy-before-pancreatic-cancer-surgery-reduces-readmission/